Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed
A home-based comprehensive care model in patients with Multiple Sclerosis: A study pre-protocol.
MRI outcomes in the diagnosis and disease course of multiple sclerosis.
Charcot-Marie-Tooth type 1C disease coexisting with progressive multiple sclerosis: a study of an overlapping syndrome.
Modern communication technology skills of patients with multiple sclerosis.
Exposure to UV Wavelengths in Sunlight Suppresses Immunity. To What Extent is UV-induced Vitamin D3 the Mediator Responsible?
Lipid profiles are associated with lesion formation over 24 months in interferon-β treated patients following the first demyelinating event.
Treatment of sleep disorders may improve fatigue in multiple sclerosis.
Comparing neuromyelitis optica and multiple sclerosis severity: is there a difference?
Epstein-Barr virus is a necessary causative agent in the pathogenesis of multiple sclerosis: Yes.
Endogenous antibodies contribute to macrophage-mediated demyelination in a mouse model for CMT1B.
Functional limitations in functional somatic syndromes and well-defined medical diseases. Results from the general population cohort LifeLines.
Immunopathology of Japanese macaque encephalomyelitis is similar to multiple sclerosis.
Trefoil factor 3 shows anti-inflammatory effects on activated microglia.
Acute hypoxic-ischemia in cardiac arrest encephalopathy causes only minimal demyelination.
Dimethyl fumarate in the management of multiple sclerosis: appropriate patient selection and special considerations.
Changes in different parameters, lymphocyte proliferation and hematopoietic progenitor colony formation in EAE mice treated with myelin oligodendrocyte glycoprotein.
Extracellular RNAs: development as biomarkers of human disease.
Neuroplasticity in Early Onset Multiple Sclerosis.
Effect of occupation on risk of developing MS: an insurance cohort study.
Objective assessment of C-fiber function by electrically induced axon reflex flare in patients with axonal and demyelinating polyneuropathy.
Desirability and expectations of the UK MS Register: Views of people with MS.
Frequency distribution of the first clinical symptoms in the Iranian population with multiple sclerosis.
HERV-W polymorphism in chromosome X is associated with multiple sclerosis risk and with differential expression of MSRV.
Current symptomatology in multiple sclerosis and neuromyelitis optica.
Therapeutic uses of anti-α4-integrin (anti-VLA-4) antibodies in multiple sclerosis.
Pages
« first
‹ previous
…
635
636
637
638
639
640
641
642
643
…
next ›
last »